Avellino News

Stay up to date with the latest Avellino news featuring global updates on innovative genetic diagnostics, gene therapy, and precision medicine.

10

14

2019

10/14/2019

Avellino Labs Receives CLIA
Certification For AvaGen

Menlo Park, California

Avellino Labs is proud to announce that it has received CLIA certification for AvaGen, a genetic diagnostic test for keratoconus and corneal dystrophies. With the certification, Avellino Labs can begin rolling out the availability of AvaGen nationwide.

06

24

2019

06/24/2019

Avellino Labs Founder Gene Lee Receives
2019 Ellis Island Medal of Honor

Menlo Park, California

Avellino Labs announced the company’s founder, chairman, and president, Gene Lee, is a recipient of a 2019 Ellis Island Medal of Honor. In addition, Mr Lee has been appointed to the World Economic Forum’s Precision Medicine Council.

05

23

2019

05/23/2019

Prominent Technologist William (Bill) F. Stasior Joins Avellino Labs Executive Advisory Committee

Menlo Park, California

Avellino Labs announced the addition of William F. Stasior to the company’s Executive Advisory Committee and consultant to the company. Mr Stasior will advance Avellino Labs genetic data management infrastructure to support the company’s growth and expanding application of its technology in health and precision medicine.

04

29

2019

04/29/2019

Avellino Labs Expands Medical Advisory Board With Internationally Renowned Ophthalmologists

Menlo Park, California

Avellino Labs, global biotechnology and genetic science innovators, announced that Eric Donnenfeld, MD; Edward Holland, MD; Richard Lindstrom, MD; and Elizabeth Yeu, MD have joined its board of medical advisors. These additions confirm Avellino Labs’ strong commitment to the future of diagnostics and therapeutic treatments for the cornea.

04

16

2019

04/16/2019

Eric Bernabei Joins Avellino Labs as Chief Sales and Marketing Officer

Menlo Park, California

Avellino Labs, global biotechnology and genetic science innovators, announced Eric Bernabei as the company’s chief sales and marketing officer (CSMO). The addition of Bernabei will further extend Avellino Labs’ leadership in global genetics and ophthalmic communities. Bernabei joins Avellino Labs with more than 20 years of product development and commercialization experience in ophthalmology.

04

05

2019

04/05/2019

Avellino Labs Welcomes James (Jim) V. Mazzo to its Board of Directors

Menlo Park, California

Avellino Labs, global biotechnology and genetic science innovators, announced the strategic addition of James (Jim) V. Mazzo to its board of directors. While Avellino Labs continues to expand its research scope and apply its technology across multiple specialties and diseases, the partnership will further anchor Avellino Lab’s leadership in developing the science and setting the standard of genetic testing in ophthalmology.


Explore More


BACK TO TOP

THIS WEBSITE USES COOKIES

By accessing and using this site, you consent to the use of cookies as described in our Privacy Policy